Feed CMT
CM

Core Molding Technologies, Inc. CMT AMEX · Basic materials · United States

$21.55 -1.42% -$0.31

Summary

50 / 100 · Bulios Score

What speaks for it

  • It could repay all its net debt from 0.7 years of operating profit.
  • It has been profitable 6 years in a row.

What to watch

  • Revenue fell by 10% a year over the last 3 years.
  • It reports a profit, yet spends more cash than it brings in.
  • You pay 26.7 USD for 1 USD of yearly profit, a lot for its sector.
  • It missed profit estimates 4 times in the last 8 quarters.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Fairly priced
Bulios Fair Price
Fair Value Price today $21.55

By our assumptions the price matches the value of the business: the two differ by less than 10 %.

P/E today 26.7 129% higher
5-year average P/E 11.6
P/E today 26.7
Chemicals - Specialty industry median

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Today you pay 26.7 USD for 1 USD of yearly profit. Over the last five years it was 11.6 USD on average.

Valuation in detail

Is it growing?

It is shrinking

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue grew by 4.3% a year over 5 years. Over the last 3 years it fell by 10% a year. Earnings per share fell by 3.6% a year over the last 3 years.

Growth in detail

Does it make money?

Poorly

Where 100 USD of revenue goes

Net profit, industry median (Chemicals - Specialty) 6.0 USD

Out of every 100 USD of revenue, 2.4 USD is left as net profit.

Profitability in detail

Is it financially healthy?

Debt is a burden

Over the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

Today's price within the analysts' price targets

The average target of $30 is 39% above today's price. 100% of the analysts recommend buying.

Analysts in detail

What does it earn on?

Fiscal year 2025

By product

By region

Product brings in 85% of revenue.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy